Last reviewed · How we verify
Diabetic Foot Infection
Approved treatments
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Diabetic Foot Infection patent landscape — cliff calendar, originator estates, attackable patents
- Diabetic Foot Infection treatment landscape brief
- Diabetic Foot Infection treatment updates RSS
Frequently asked questions about Diabetic Foot Infection
What drugs treat Diabetic Foot Infection?
Tracked treatments include Pipracil, Invanz, Primaxin, Zosyn.
What is the treatment for Diabetic Foot Infection?
Standard treatment for Diabetic Foot Infection includes Pipracil, Invanz, Primaxin, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Diabetic Foot Infection patent cliff · Diabetic Foot Infection CI report
- Treatment: Pipracil
- Treatment: Invanz · Merck & Co.
- Treatment: Primaxin · Merck Sharp & Dohme B.V.
- Treatment: Primaxin · Merck & Co.
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing